Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
Showing 10,621–10,680 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
…e production. OX40-mAbs were widely tested for immunotherapy in solid tumors (agonist), and autoimmune diseases (antagonist), with well-know…
…an irreversible inhibitor of AC, was evaluated in an orthotopic oligodendroglioma xenograft mice model using TS603 patient-derived oligodendrogli…
…found that CD24 copy number gain is most frequently observed in ovarian cancer, sarcomas, and non-seminomatous germ cell tumors (>30% of tumor…
…Background Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine carcinoma with an immunos…
…d to both published 1-3 and two new cohorts (n=45 and n=136) of non-small cell lung cancer (NSCLC) patients, to uncover consistent predictors of ICI respo…
…Background Lung cancer molecular disparities may impact access to targeted therapies a…
…in-directed CAR T cells for specific and effective targeting of glioblastoma. Sci Transl Med. 2020 Mar 4;12(533)Ethics Approval The trial ( …
…AMs) promote angiogenesis, metastasis, and immunosuppression in breast cancer (BC), contributing to resistance to immune checkpoint blockade …
…the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma. Cells. 2019 Sep 11;8(9):1070.Wilkie S, Picco G, Foster J, Davi…
…an GBM orthotopic model using the GBM01 cell line.Methods Human GBM01 GFP-Luc cells were stereotaxically injected into the brain of N…
…(p50-IMC) slows the growth of syngeneic murine prostate cancer, pancreatic ductal carcinoma, neuroblastoma, and glioblastoma tumors, when given after a dos…
…Background Bladder Cancer is the fourth most common cancer in men and a leading cause of …